Dr. Ramin Mehdian, MD

Dr. Mehdian practices at Ramin Mehdian Medical Corporation in Newbury Park, California.

Dr. Mehdian's NPI, 1053457127, was assigned on January 29, 2007. Dr. Mehdian graduated from New York Medical College in 1995. Dr. Mehdian holds California license A62908.

Dr. Mehdian's primary practice is Ramin Mehdian Medical Corporation, at 1000 Newbury Rd, Newbury Park, CA 91320 in Ventura County. The practice phone is (805) 499-4143.

Dr. Mehdian's primary practice is Ramin Mehdian Medical Corporation in Newbury Park, California. Dr. Mehdian is also affiliated with Dignity Health - Northridge Hospital Medical Center. The medical group on file is Ramin Mehdian, MD. Dmand AI also links Dr. Mehdian to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehdian practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mehdian's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mehdian is board certified in neurocritical care by the American Board of Emergency Medicine. Dr. Mehdian is licensed in California.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pleural effusion and pneumonia among the conditions Dr. Mehdian treats.

CMS data shows 5,945 Medicare services from Dr. Mehdian across 23 procedure codes in 2024, for 1,024 Medicare patients. Medicare paid $542,187 for them.

CMS counts 1,024 Medicare patients who saw Dr. Mehdian in 2024. The largest group is 75 to 84, with 450 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehdian's median patient age at 75, with 52% women.

In 2024, Dr. Mehdian wrote 4,314 Medicare Part D claims for 499 patients. 60% of them were for generic drugs. CMS names the drug for 3,819 of them, across 68 drugs with 11 or more claims each, at $1,085,485 in total drug cost. In 2023, CMS named 4,005 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Mehdian for performance year 2024, reported individually. Dr. Mehdian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehdian as offering telehealth.

Dmand AI links 1 paper to Dr. Mehdian.

CMS Open Payments shows 44 general payments to Dr. Mehdian from 9 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 72% of the total. AstraZeneca Pharmaceuticals LP paid the most, $651.

Dr. Mehdian graduated from New York Medical College in 1995. Dr. Mehdian is a member of ACP.

Dr. Mehdian is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.